A new model to determine Optimal Exposure to Tacrolimus and Mycophenolate Mofetil after renal transplantation

Pankewycz O., ONAN E., Rucker D., Wang D., Gruessner A., Gruessner R., ...Daha Fazla

CLINICAL TRANSPLANTATION, cilt.34, sa.7, 2020 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 34 Sayı: 7
  • Basım Tarihi: 2020
  • Doi Numarası: 10.1111/ctr.13893
  • Dergi Adı: CLINICAL TRANSPLANTATION
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CAB Abstracts, EMBASE, MEDLINE
  • Çukurova Üniversitesi Adresli: Evet

Özet

Background Drug dosing for Tacrolimus (TAC) and Mycophenolate Mofetil (MMF) after kidney transplantation remains challenging. Therapeutic drug monitoring (TDM) offers a means to individualize drug dosing and improve outcomes.